Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-May-15 6:05 AM View:  | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 26-May-15 | Market Purchase | 63,900 | $2.91 | $185,949.00 | 5% 1.17M to 1.23M | (84%) |
| 07-May-15 4:35 PM View: | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 06-May-15 | Market Purchase | 50,000 | $3.47 | $173,500.00 | 4% 1.12M to 1.17M | (87%) |
| 20-Apr-15 11:08 AM View: | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 16-Apr-15 | Market Purchase | 35,000 | $3.82 | $133,700.00 | 3% 1.08M to 1.12M | (88%) |
| 03-Feb-15 2:56 PM View: | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 02-Feb-15 | Market Purchase | 38,730 | $4.21 | $163,053.00 | 4% 1.04M to 1.08M | (89%) |
| 29-Dec-14 10:45 AM View: | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 23-Dec-14 | Market Purchase | 70,800 | $4.28 | $303,024.00 | 7% 972.72K to 1.04M | (89%) |
| 11-Dec-14 3:23 PM View: | Gregory John M 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 10-Dec-14 | Market Purchase | 103,016 | $4.56 | $469,753.00 | 12% 869.7K to 972.72K | (90%) |
| 12-Mar-14 5:00 PM View: | Lu Weibing Chief Executive Officer Director 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 10-Mar-14 | Grant | 250,000 | -- | -- | 21% 1.17M to 1.42M | |
| 12-Mar-14 5:02 PM View: | Mei Bing Chief Financial Officer | Skystar Bio-Pharmaceutical Co (SKBI) | 10-Mar-14 | Grant | 8,000 | -- | -- | 44% 18.0K to 26.0K | |
| 17-May-12 9:31 AM View: | Fan Qiang Director | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 10,000 | $2.58 | $25,800.00 | 100% 0 to 10.0K | (82%) |
| 08-May-12 4:45 PM View: | Wen Wei Vice President, Secretary Director | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 42,000 | $2.58 | $108,360.00 | 101% 41.54K to 83.54K | (82%) |
| 08-May-12 4:48 PM View: | Mei Bing Chief Financial Officer | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 18,000 | $2.58 | $46,440.00 | 100% 0 to 18.0K | (82%) |
| 08-May-12 4:46 PM View: | Chen Mark D Director | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 21,112 | $2.58 | $54,469.00 | 380% 5.56K to 26.67K | (82%) |
| 17-May-12 9:15 AM View: | Shen Weirong Director | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 1,900 | $2.58 | $4,902.00 | 100% 0 to 1.9K | (82%) |
| 08-May-12 4:47 PM View: | Lu Weibing Chief Executive Officer Director 10% Owner | Skystar Bio-Pharmaceutical Co (SKBI) | 04-May-12 | Grant | 233,333 | $2.58 | $601,999.00 | 25% 939.13K to 1.17M | (82%) |
| 28-May-09 6:07 PM View: | Lientz Bennet Price Jr Chief Financial Officer | Skystar Bio-Pharmaceutical Co (SKBI) | 26-May-09 | Grant | 7,220 | -- | -- | 138% 5.22K to 12.44K | |
| 29-May-09 1:19 PM View: | Chen Mark D Director | Skystar Bio-Pharmaceutical Co (SKBI) | 26-May-09 | Grant | 2,778 | -- | -- | 100% 0 to 2.78K | |
| 06-May-08 7:16 PM View: | Lientz Bennet Price Jr Chief Financial Officer | Skystar Bio-Pharmaceutical Co (SKBI) | 05-May-08 | Grant | 52,173 | -- | -- | 100% 0 to 52.17K |
